Anselme Perrier, Ph.D.

Affiliations: 
INSERM, Rennes, Bretagne, France 
Google:
"Anselme Perrier"
Mean distance: 17.37 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Grealish S, Diguet E, Kirkeby A, et al. (2014) Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease. Cell Stem Cell. 15: 653-65
Drouet V, Ruiz M, Zala D, et al. (2014) Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells. Plos One. 9: e99341
Nicoleau C, Varela C, Bonnefond C, et al. (2013) Embryonic stem cells neural differentiation qualifies the role of Wnt/β-Catenin signals in human telencephalic specification and regionalization. Stem Cells (Dayton, Ohio). 31: 1763-74
Charbord J, Poydenot P, Bonnefond C, et al. (2013) High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes. Stem Cells (Dayton, Ohio). 31: 1816-28
Viegas P, Nicoleau C, Perrier AL. (2012) Derivation of striatal neurons from human stem cells. Progress in Brain Research. 200: 373-404
Perrier A, Peschanski M. (2012) How can human pluripotent stem cells help decipher and cure Huntington's disease? Cell Stem Cell. 11: 153-61
Feyeux M, Bourgois-Rocha F, Redfern A, et al. (2012) Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells. Human Molecular Genetics. 21: 3883-95
Kafert-Kasting S, Schneider A, Attaran M, et al. (2012) Safety assessment of intraportal liver cell application in New Zealand white rabbits under GLP conditions. Archives of Toxicology. 86: 1413-22
Nicoleau C, Viegas P, Peschanski M, et al. (2011) Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 8: 562-76
Seminatore C, Polentes J, Ellman D, et al. (2010) The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke; a Journal of Cerebral Circulation. 41: 153-9
See more...